|
US3145209A
(en)
|
1961-07-31 |
1964-08-18 |
Olin Mathieson |
Substituted aminophenyl-ethylamine derivatives
|
|
US3975443A
(en)
|
1972-06-06 |
1976-08-17 |
Allen & Hanburys Limited |
1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
EP0687268B1
(en)
|
1993-03-04 |
1998-05-27 |
Pfizer Inc. |
Spiroazacyclic derivatives as substance p antagonists
|
|
AU691829B2
(en)
|
1993-07-16 |
1998-05-28 |
Merck & Co., Inc. |
Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
|
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
|
PL318298A1
(en)
|
1994-07-20 |
1997-06-09 |
Byk Gulden Lomberg Chem Fab |
Thiopyridil compounds for fighting against heliobacter
|
|
FR2731222A1
(fr)
|
1995-03-02 |
1996-09-06 |
Pf Medicament |
Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5939418A
(en)
|
1995-12-21 |
1999-08-17 |
The Dupont Merck Pharmaceutical Company |
Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors
|
|
DE19548624A1
(de)
|
1995-12-23 |
1997-06-26 |
Boehringer Mannheim Gmbh |
Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US6333322B1
(en)
|
1996-03-13 |
2001-12-25 |
Eisai Co., Ltd. |
Nitrogen-containing tricyclic compounds and drugs containing the same
|
|
AU707347B2
(en)
|
1996-04-03 |
1999-07-08 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859012A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5885995A
(en)
|
1996-04-03 |
1999-03-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036592A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
DE19700431A1
(de)
|
1997-01-10 |
1998-07-16 |
Basf Ag |
Reaktivfarbstoffe mit einem Disulfonylanker
|
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
CN1290254A
(zh)
|
1998-02-05 |
2001-04-04 |
武田药品工业株式会社 |
氨磺酰衍生物及其制备和用途
|
|
GB9806287D0
(en)
|
1998-03-24 |
1998-05-20 |
Synphar Lab Inc |
Monobactam enzyme inhibitors
|
|
TWI220143B
(en)
|
1998-05-13 |
2004-08-11 |
Solvay Pharm Gmbh |
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
|
|
US6380193B1
(en)
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
CA2332239A1
(en)
|
1998-05-15 |
1999-11-25 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
|
WO2000042852A1
(en)
|
1999-01-25 |
2000-07-27 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
US6358956B1
(en)
|
1999-03-03 |
2002-03-19 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
EP1165084A4
(en)
|
1999-03-03 |
2002-05-15 |
Merck & Co Inc |
INHIBITORS OF PRENYL PROTEIN TRANSFERASES
|
|
US6335343B1
(en)
|
1999-03-03 |
2002-01-01 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
EP1158983A4
(en)
|
1999-03-03 |
2003-05-21 |
Merck & Co Inc |
Prenyl protein transferase inhibitors
|
|
CA2363169A1
(en)
|
1999-03-03 |
2000-09-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
DE19911510A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
AU5464200A
(en)
|
1999-06-09 |
2000-12-28 |
Merck & Co., Inc. |
Biaryl inhibitors of prenyl-protein transferase
|
|
AU5567000A
(en)
|
1999-06-24 |
2001-01-09 |
Toray Industries, Inc. |
Alpha1b-adrenergic receptor antagonists
|
|
WO2001014331A2
(en)
|
1999-08-24 |
2001-03-01 |
Regents Of The University Of California |
Non-quinoline inhibitors of malaria parasites
|
|
DE19944066A1
(de)
|
1999-09-14 |
2001-03-15 |
Byk Gulden Lomberg Chem Fab |
Inhibitoren der Tryptase
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
KR20010087401A
(ko)
|
1999-09-28 |
2001-09-15 |
스타르크, 카르크 |
아제피노인돌 유도체, 그의 제법 및 용도
|
|
US20020052380A1
(en)
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020010184A1
(en)
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
WO2001076693A1
(en)
|
2000-04-10 |
2001-10-18 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
AU2002211280A1
(en)
|
2000-09-29 |
2002-04-08 |
Cor Therapeutics, Inc. |
Piperazin-2-one amides as inhibitors of factor Xa
|
|
US20020124273A1
(en)
|
2000-10-17 |
2002-09-05 |
Jean-Marc Roch |
Protein-protein interactions in neurodegenerative diseases
|
|
US20040180925A1
(en)
|
2000-12-27 |
2004-09-16 |
Kenji Matsuno |
Dipeptidylpeptidase-IV inhibitor
|
|
SE0100902D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
US20030158209A1
(en)
|
2001-10-09 |
2003-08-21 |
Neurocrine Biosciences Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US7294624B2
(en)
|
2001-12-20 |
2007-11-13 |
Bristol Myers Squibb Company |
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
|
|
AU2002346729A1
(en)
|
2001-12-20 |
2003-07-09 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
|
|
EP1469851B1
(en)
|
2002-01-23 |
2006-10-11 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
NZ536116A
(en)
|
2002-04-03 |
2007-01-26 |
Topotarget Uk Ltd |
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
|
|
CN100360130C
(zh)
|
2002-04-18 |
2008-01-09 |
先灵公司 |
用作组胺h3拮抗剂的1－(4－哌啶基)苯并咪唑酮
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
US20050209278A1
(en)
|
2002-04-25 |
2005-09-22 |
Mcdonald Joseph J |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
CA2483314A1
(en)
|
2002-04-25 |
2003-11-06 |
Pharmacia Corporation |
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
MY135686A
(en)
|
2002-06-24 |
2008-06-30 |
Schering Corp |
Indole derivatives useful as histamine h3 antagonists
|
|
US6906096B2
(en)
|
2002-06-28 |
2005-06-14 |
Irm Llc |
4,7-Disubstituted indoles and methods of making
|
|
JP4579681B2
(ja)
|
2002-07-09 |
2010-11-10 |
ブリストル−マイヤーズ スクイブ カンパニー |
抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法
|
|
WO2004010942A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
|
CA2499732A1
(en)
|
2002-09-20 |
2004-04-15 |
Applied Research Systems Ars Holding N.V. |
Piperazine derivatives and methods of use
|
|
WO2004037817A1
(ja)
|
2002-10-25 |
2004-05-06 |
Mitsubishi Pharma Corporation |
Ｎ−オキシド化合物
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20050043533A1
(en)
|
2003-03-25 |
2005-02-24 |
Babiak Kevin A. |
Process for making alpha-substituted hydroxamic acids
|
|
WO2004099179A1
(en)
|
2003-05-07 |
2004-11-18 |
Actelion Pharmaceuticals Ltd |
Piperazine-alkyl-ureido derivatives
|
|
ATE440825T1
(de)
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
ES2385219T3
(es)
*
|
2003-09-12 |
2012-07-19 |
Merck Serono Sa |
Derivados de sulfonamida para el tratamiento de diabetes
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
GB0328900D0
(en)
|
2003-12-12 |
2004-01-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2005058823A1
(ja)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
ウレア誘導体、その製造法及び用途
|
|
WO2005063247A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
|
JP2005232306A
(ja)
|
2004-02-19 |
2005-09-02 |
Fuji Photo Film Co Ltd |
光重合性組成物及びそれを用いた記録材料
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
WO2005087765A1
(en)
|
2004-03-04 |
2005-09-22 |
Arena Pharmaceuticals, Inc. |
Ligands of follicle stimulating hormone receptor and methods of use thereof
|
|
US20050197336A1
(en)
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
|
CA2559285A1
(en)
|
2004-03-18 |
2005-09-29 |
Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies
|
|
SE0400850D0
(sv)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
|
US7345043B2
(en)
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
|
WO2005117882A2
(en)
|
2004-04-20 |
2005-12-15 |
Incyte Corporation |
Hydroxamic acid derivatives as metalloprotease inhibitors
|
|
GB0408777D0
(en)
*
|
2004-04-20 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
AP2353A
(en)
|
2004-05-07 |
2012-02-16 |
Warner Lambert Co |
3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands.
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
EP1756056A1
(en)
|
2004-06-08 |
2007-02-28 |
Pfizer Products Inc. |
Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
|
|
US20060241118A1
(en)
|
2004-06-18 |
2006-10-26 |
Celltech R&D Limited |
Hydroxamate sulfonamides as cd23 shedding inhibitors
|
|
CA2571824A1
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2006008644A1
(en)
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
|
CA2574307A1
(en)
|
2004-07-22 |
2006-02-02 |
Cumbre Pharmaceuticals Inc. |
Rifamycin derivatives for treating microbial infections
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
PE20060653A1
(es)
|
2004-08-31 |
2006-09-27 |
Glaxo Group Ltd |
Derivados triciclicos condensados como moduladores del receptor 5-ht1
|
|
US7767677B2
(en)
|
2004-09-20 |
2010-08-03 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
CN101083986A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
|
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
WO2006057303A1
(ja)
|
2004-11-29 |
2006-06-01 |
National University Corporation Nagoya University |
グリコペプチド抗生物質モノマー誘導体
|
|
PL1828154T3
(pl)
*
|
2004-12-09 |
2009-10-30 |
Hoffmann La Roche |
Pochodne fenylopiperazynometanonu
|
|
JP2008525398A
(ja)
|
2004-12-23 |
2008-07-17 |
グラクソ グループ リミテッド |
グリシン輸送阻害剤
|
|
GB0428233D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
PE20061330A1
(es)
|
2004-12-23 |
2006-12-27 |
Glaxo Group Ltd |
Compuestos derivados de benzamida como inhibidores del transportador de glicina
|
|
PE20061156A1
(es)
|
2004-12-23 |
2006-12-16 |
Glaxo Group Ltd |
Derivados de benzamida como agentes inhibidores del transportador de glicina
|
|
GB0428232D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
WO2006071875A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
US7635698B2
(en)
|
2004-12-29 |
2009-12-22 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
ATE472327T1
(de)
*
|
2005-01-07 |
2010-07-15 |
Hoffmann La Roche |
Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
|
|
EP1851203A2
(en)
|
2005-02-08 |
2007-11-07 |
Merck & Co., Inc. |
Inhibitors of checkpoint kinases
|
|
WO2006102423A1
(en)
|
2005-03-21 |
2006-09-28 |
Celera Genomics |
Alpha ketoamide compounds as cysteine protease inhibitors
|
|
DE102005014936A1
(de)
|
2005-03-24 |
2006-12-14 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
|
WO2006105127A2
(en)
|
2005-03-31 |
2006-10-05 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
EP1902051A1
(en)
|
2005-06-09 |
2008-03-26 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2006138218A1
(en)
|
2005-06-13 |
2006-12-28 |
Theravance, Inc. |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
CA2609957A1
(en)
|
2005-06-20 |
2007-01-04 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
|
DE602006010870D1
(de)
|
2005-06-20 |
2010-01-14 |
Schering Corp |
Als antagonisten von histamin h3 geeignete piperidinderivate
|
|
WO2007016496A2
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
EP1942733B1
(en)
*
|
2005-09-29 |
2012-03-21 |
Merck Sharp & Dohme Corp. |
Radiolabeled glycine transporter inhibitors
|
|
DE602006018172D1
(de)
*
|
2005-10-06 |
2010-12-23 |
Sanofi Aventis |
Cyclische n-ä1,3,4ü-thiadiazol-2-yl-benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007057742A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Novel piperazinone derivatives
|
|
WO2007075377A2
(en)
|
2005-12-15 |
2007-07-05 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
CA2634235A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Combination of an h3 antagonist/inverse agonist and an appetite suppressant
|
|
CA2634940A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
|
|
AU2006331850A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Substituted aniline derivatives useful as histamine H3 antagonists
|
|
JP2009521448A
(ja)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
ヒスタミンｈ３アンタゴニストとして有用なフェノキシピペリジンおよびそのアナログ
|
|
KR101294014B1
(ko)
|
2006-01-06 |
2013-08-09 |
선오비온 파마슈티컬스 인코포레이티드 |
모노아민 재흡수 저해제로서의 시클로알킬아민
|
|
GB0600427D0
(en)
|
2006-01-10 |
2006-02-15 |
Glaxo Group Ltd |
Compounds
|
|
KR20080098490A
(ko)
|
2006-01-13 |
2008-11-10 |
파마시클릭스, 인코포레이티드 |
티로신 키나제 억제제 및 이의 용도
|
|
WO2007087220A2
(en)
|
2006-01-25 |
2007-08-02 |
The Trustees Of Columbia University In The City Of New York |
The total synthesis of ecteinascidin 743 and derivatives thereof
|
|
AR059355A1
(es)
|
2006-02-07 |
2008-03-26 |
Wyeth Corp |
Inhibidores de 11-beta hsd1
|
|
RU2008136391A
(ru)
|
2006-02-10 |
2010-03-20 |
Янссен Фармацевтика Н.В. (Be) |
Пиперидиновые производные в качестве антагонистов рецептора cхcr3
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
US20090281097A1
(en)
|
2006-04-14 |
2009-11-12 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
|
WO2007133491A1
(en)
|
2006-05-09 |
2007-11-22 |
Merck & Co., Inc. |
Substituted spirocyclic cgrp receptor antagonists
|
|
TW200808818A
(en)
|
2006-05-26 |
2008-02-16 |
Shionogi & Co |
Glycopeptide antibiotic derivatives
|
|
WO2007139150A1
(ja)
|
2006-05-30 |
2007-12-06 |
The University Of Tokushima |
ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤
|
|
WO2007143745A2
(en)
|
2006-06-09 |
2007-12-13 |
Icos Corporation |
Substituted phenyl acetic acids as dp-2 antagonists
|
|
GB0612437D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612425D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612416D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612420D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612435D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
UA94615C2
(uk)
*
|
2006-06-28 |
2011-05-25 |
Амген Інк. |
Інгібітори транспортера-1 гліцину
|
|
SG172685A1
(en)
|
2006-06-28 |
2011-07-28 |
Amgen Inc |
Glycine transporter-1 inhibitors
|
|
ES2596706T3
(es)
*
|
2006-06-29 |
2017-01-11 |
F. Hoffmann-La Roche Ag |
Arilamidas con sustitución de tetrazol
|
|
JP2008013527A
(ja)
|
2006-07-10 |
2008-01-24 |
Sankyo Co Ltd |
チエノ［３，２−ｄ］ピリミジン−２，４−ジアミン誘導体
|
|
DE102006033114A1
(de)
|
2006-07-18 |
2008-01-24 |
Grünenthal GmbH |
Spirocyclische Azaindol-Derivate
|
|
ATE467413T1
(de)
|
2006-09-21 |
2010-05-15 |
Hoffmann La Roche |
Oxindolderivate als antikrebsmittel
|
|
GB0621607D0
(en)
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
PE20080931A1
(es)
|
2006-11-08 |
2008-07-19 |
Schering Corp |
Imidazopirazinas como inhibidores de proteina quinasa
|
|
JP5084839B2
(ja)
*
|
2006-11-09 |
2012-11-28 |
エフ．ホフマン−ラ ロシュ アーゲー |
チアゾール及びオキサゾール置換アリールアミド
|
|
US20080153810A1
(en)
|
2006-11-15 |
2008-06-26 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
KR20080045537A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
|
CN101558038B
(zh)
|
2006-11-30 |
2013-05-01 |
国立大学法人东京工业大学 |
姜黄素衍生物
|
|
RU2478619C2
(ru)
|
2006-12-11 |
2013-04-10 |
Ривайва Фармасьютикалс, Инк. |
Композиции, синтез и способы применения ингибиторов холинэстеразы на основе инданона
|
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
EP2144890A1
(en)
|
2007-02-07 |
2010-01-20 |
Wyeth |
Method for preparing halogenated amines
|
|
US20100216992A1
(en)
|
2007-02-27 |
2010-08-26 |
University Of South Florida |
Mimetic compositions and the production thereof
|
|
US8138333B2
(en)
|
2007-03-13 |
2012-03-20 |
Proximagen Limited |
Sulfonyl-indole derivatives
|
|
US8536168B2
(en)
|
2007-03-15 |
2013-09-17 |
Novartis Ag |
Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
|
|
CN101679220A
(zh)
|
2007-04-09 |
2010-03-24 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
|
JP2008266236A
(ja)
|
2007-04-23 |
2008-11-06 |
Kyorin Pharmaceut Co Ltd |
環状アミン誘導体又はその塩
|
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
|
CA2687931C
(en)
|
2007-05-31 |
2016-05-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
JP2010208945A
(ja)
|
2007-06-01 |
2010-09-24 |
Mitsubishi Tanabe Pharma Corp |
複素環化合物
|
|
EP2170820A2
(en)
|
2007-06-20 |
2010-04-07 |
Glaxo Group Limited |
Improved process of amide formation
|
|
US7842696B2
(en)
*
|
2007-06-21 |
2010-11-30 |
Forest Laboratories Holdings Limited |
Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
|
|
WO2009005646A2
(en)
|
2007-06-28 |
2009-01-08 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
|
WO2009005645A1
(en)
|
2007-06-28 |
2009-01-08 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
|
CN101790521A
(zh)
|
2007-06-28 |
2010-07-28 |
英特维特国际股份有限公司 |
作为cb1拮抗剂的取代哌嗪
|
|
WO2009013535A1
(en)
|
2007-07-23 |
2009-01-29 |
Astrazeneca Ab |
2-azabicyclo(2.2.2)octane derivatives as modulators of the glycine transporter i receptor
|
|
JP5160827B2
(ja)
|
2007-07-25 |
2013-03-13 |
塩野義製薬株式会社 |
グリコペプチド抗生物質誘導体
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
CN102083990B
(zh)
|
2008-07-04 |
2016-05-04 |
财富科学家股份有限公司 |
通过3-羟基烷酸的酶促脱羧制备烯
|
|
WO2011153359A1
(en)
|
2010-06-04 |
2011-12-08 |
Albany Molecular Research, Inc. |
Glycine transporter-1 inhibitors, methods of making them, and uses thereof
|